Condition: Acute Respiratory Distress Syndrome · Sponsor: Toray Industries, Inc
The primary object of this clinical study is to investigate the efficacy and the safety of NOA-001 in patients with ARDS (ARDS caused by Non-COVID-19 or COVID-19).
This description comes directly from the study's public registry record.
NOA-001 Team · +81 3 3245 8588 · clinical-trials.toray.mb@mail.toray
Always discuss trial participation with your own doctor first.
| Showa University Hospital | Tokyo, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04804943